Cargando…
Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants
Liquid biopsies are an integral part of the diagnosis of cancer. Here, we have extended previous validation studies of a new targeted NGS panel to include the detection of copy number amplifications (CNAs), fusions, and exon skipping variants. Detection of these gene classes included specimens from...
Autores principales: | Audetat, Audrey, Tschida, Chérie, Kreston, Sarah, Stephen, Adam, D’Alessio, Brittany, Bondy, Madeline, Jackson, Leisa, Mellert, Hestia, Givens, Niki, Sathyanarayana, Ubaradka G., Pestano, Gary A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947661/ https://www.ncbi.nlm.nih.gov/pubmed/35328282 http://dx.doi.org/10.3390/diagnostics12030729 |
Ejemplares similares
-
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
por: Mellert, Hestia, et al.
Publicado: (2021) -
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
por: Mellert, Hestia S., et al.
Publicado: (2018) -
Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors
por: Jackson, Leisa P., et al.
Publicado: (2020) -
Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR
por: Bowling, Mark, et al.
Publicado: (2019) -
Design and Characterization of a Novel Blood Collection and Transportation Device for Proteomic Applications
por: Kaiser, Nathan K., et al.
Publicado: (2020)